Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

Astrazeneca image

RA setbacks for AstraZeneca and Lilly

December 14, 2012
Research and Development, Sales and Marketing AstraZeneca, Humira, RA, lilly

AstraZeneca and Eli Lilly have both suffered setbacks in their attempts to push their respective investigational rheumatoid arthritis (RA) treatments …

News
Forxiga image

Forxiga approved in European Union

November 15, 2012
Sales and Marketing AstraZeneca, BMS, Forxiga, diabetes

AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga has been approved in Europe – a major filip for …

News

Germany dismisses Seroquel XR

November 14, 2012
Sales and Marketing AstraZeneca, FDA, Germany, Seroquel XR

AstraZeneca has received another dent in its international attempts to keep the money-spinning antipsychotic Seroquel going in a new form. …

News

AstraZeneca signs genome deal

November 13, 2012
Research and Development, Sales and Marketing AstraZeneca, Foundation, SMIP

AstraZeneca has signed a genomic profiling agreement with US molecular information company Foundation Medicine. The collaboration will use its FoundationOne …

News
Astrazeneca image

MRC gives £7 million to new projects

November 6, 2012
Sales and Marketing AstraZeneca, MRC, academics

The Medical Research Council (MRC) has handed out £7 million in funding for 15 research projects which will use a …

News
Astrazeneca image

Sharp fall for AstraZeneca

October 26, 2012
Sales and Marketing AstraZeneca, Brennan, Q3, Soriot

AstraZeneca saw its third quarter revenue and pre-tax profit both fall 15%, to $6.7 billion and $2 billion, respectively. The …

News
Astrazeneca image

AstraZeneca and Ironwood announce $150 million China pact

October 25, 2012
Research and Development, Sales and Marketing AstraZeneca, China, IBS, Ironwood

AstraZeneca has signed a deal with Ironwood to co-develop and co-market Ironwood’s irritable bowel syndrome treatment in China. In August …

News
Astrazeneca image

AZ licences renal disease compound

October 9, 2012
Research and Development, Sales and Marketing Ardelyx, AstraZeneca, NHE3

AstraZeneca has signed an agreement giving it worldwide exclusive rights to California-based Ardelyx’s NHE3 inhibitor programme targeting liver and kidney …

News

Pharma creates non-profit R&D organisation

September 21, 2012
Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma

Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …

News
Mark Mallon image

Asia-Pacific – pharma’s new centre of gravity?

September 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia-Pacific, AstraZeneca

A high-growth region for the pharmaceutical industry, Asia-Pacific incorporates a vast geography with a $20 trillion economy, and is home …

Feature
Astrazeneca image

AstraZeneca signs MIT/Harvard research deal

September 17, 2012
Business Services, Research and Development, Sales and Marketing AstraZeneca, Deals, Havard, MIT

AstraZeneca has signed a two-year collaboration with an academic institution – affiliated to the illustrious universities MIT and Harvard – …

News
MedImmune

MedImmune signs China deal

September 11, 2012
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis

MedImmune has sealed a joint venture with Shanghai-based WuXi AppTec to develop a novel biologic for autoimmune and inflammatory diseases …

News
Pascal Soirot takes over in October

AstraZeneca poaches Soirot from Roche to be new chief executive

August 28, 2012
Sales and Marketing AstraZeneca, Soirot

AstraZeneca has poached Roche’s head of pharma, Pascal Soriot, to be its new chief executive. He joins on 1 October. …

News
Nexium image

Pfizer pays $250m for OTC Nexium rights

August 14, 2012
Sales and Marketing AstraZeneca, EMA, FDA, Nexium, OTC, Pfizer

Pfizer will pay $250 million to AstraZeneca in order to gain the rights to sell an over-the-counter form of the …

News
Astrazeneca image

AstraZeneca and BTG sepsis drug fails

August 8, 2012
Research and Development, Sales and Marketing AZD977, AstraZeneca, BTG, CytoFab, sepsis

AstraZeneca’s pipeline has suffered another blow with the troubled company halting development of an investigational sepsis drug following poor Phase …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025